How many drugs treat Acute exacerbation of asthma?

Drug Landscape tracks 10 marketed treatments for Acute exacerbation of asthma (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

What's the most recent regulatory action in Acute exacerbation of asthma?

Most recent: Bupivacaine Hydrochloride And Epinephrine — FDA approved.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/acute-exacerbation-of-asthma.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Acute exacerbation of asthma — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acute exacerbation of asthma (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Acute exacerbation of asthma, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Xopenex	LEVOSALBUTAMOL	Oak Pharms Inc	beta2-Adrenergic Agonist	Beta-2 adrenergic receptor	1999-01-01
Tornalate	BITOLTEROL	Sanofi	bitolterol	Beta-2 adrenergic receptor	1984-01-01
ProAir	albuterol	Generic (originally Allen & Hanburys/GSK)	SABA (Short-acting beta-2 agonist)	Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Beta-2 adrenergic receptor	1982-05-05
Proventil	salbutamol	Merck & Co.	beta2-Adrenergic Agonist	Beta-2 adrenergic receptor	1981-01-01
Norepinephrine Bitartrate In 5% Dextrose	NOREPINEPHRINE	Pfizer	Catecholamine	alpha-adrenergic receptors, beta-adrenergic receptors	1950-01-01
Bupivacaine Hydrochloride And Epinephrine	Epinephrine	Pfizer Inc.	alpha-Adrenergic Agonist [EPC]	Alpha-1D adrenergic receptor	1948-01-01
Epinephrin	Epinephrin	United States Naval Medical Center, San Diego		Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor
Aminophyllin	Aminophyllin	University of Padova		Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1
xopenex	xopenex	Phoenix Children's Hospital		Beta-2 adrenergic receptor
Noradrenaline	Noradrenaline	Tanta University		Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

2026-03-30 — Bupivacaine Hydrochloride And Epinephrine · FDA · approved · US
2026-03-26 — Norepinephrine Bitartrate In 5% Dextrose · FDA · approved · US

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 3 drugs in Acute exacerbation of asthma
Pfizer Inc. · 2 drugs in Acute exacerbation of asthma
Merck & Co. · 1 drug in Acute exacerbation of asthma
Oak Pharms Inc · 1 drug in Acute exacerbation of asthma
Pfizer · 1 drug in Acute exacerbation of asthma
Phoenix Children's Hospital · 1 drug in Acute exacerbation of asthma
Sanofi · 1 drug in Acute exacerbation of asthma
Tanta University · 1 drug in Acute exacerbation of asthma
United States Naval Medical Center, San Diego · 1 drug in Acute exacerbation of asthma
University of Aleppo · 1 drug in Acute exacerbation of asthma
University of Bergen · 1 drug in Acute exacerbation of asthma
University of Padova · 1 drug in Acute exacerbation of asthma

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Acute exacerbation of asthma:

Cite this brief

Drug Landscape (2026). Acute exacerbation of asthma — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/acute-exacerbation-of-asthma. Accessed 2026-06-10.

Acute exacerbation of asthma full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing